Skip to main content
Fig. 3 | Clinical Epigenetics

Fig. 3

From: DNA methylation and cancer incidence: lymphatic–hematopoietic versus solid cancers in the Strong Heart Study

Fig. 3

Differentially methylated region for lymphatic–hematopoietic cancer. Hazard ratios (95% confidence intervals) and genomic location of the top 2 differentially methylated region for lymphatic–hematopoietic cancers including 41 CpG sites. Orange bars represent overlapping promoters. Locations of CpGs of the differentially methylated region in the chromosome are represented by blue vertical bars above the overlapping promoters. The grey area in the plot represents the differentially methylated region

Back to article page